Drugs that contain Ganciclovir

1. Ganzyk-rtu patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9486530 EXELA PHARMA Ganciclovir compositions and related methods
Sep, 2034

(10 years from now)

Market Authorisation Date: 17 February, 2017

Treatment: NA


More Information on Dosage

GANZYK-RTU family patents

Family Patents